Endogenous heparin activity deficiency: the 'missing link' in atherogenesis? (Q34455024)

2 August 2017

1 reference

title

Endogenous heparin activity deficiency: the 'missing link' in atherogenesis? (English)

1 reference

2 August 2017

1 reference

H Engelberg

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

159

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

253-260

1 reference

Evidence that endogenous heparin activity deficiency may be an important factor in atherogenesis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Plasma heparin levels in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Endogenous heparinase-sensitive anticoagulant activity in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Human endogenous plasma lipemia clearing activity, observations in 482 individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Chemokines: leucocyte recruitment and activation cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

On the edge: the physiological and pathophysiological role of chemokines during inflammatory and immunological responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Human chemokines: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

The role of lipoprotein(a) in atherogenesis and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Evidence that macrophages in atherosclerotic lesions contain angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Heparin prevents the binding of phospholipase A2 to phospholipid micelles: importance of the amino-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Cytomegalovirus infection induces vascular injury in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Viral genomes and arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Leukocyte-endothelium adhesion molecules in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

A role for beta(2) integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Advanced protein glycosylation in diabetes and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Extra- and intracellular localization of advanced glycation end-products in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Expression of functional CD40 by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

CD40 signaling in vascular cells: a key role in atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

CD40 ligation induces tissue factor expression in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Requirement for CD154 in the progression of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Apolipoprotein E Alleles and Risk of Coronary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Functions of the endothelial cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Inhibition of proteoglycan synthesis in human endothelial cells after infection with herpes simplex virus type 1 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Matrix metalloproteinases can facilitate the heparanase-induced promotion of phenotypic change in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Acidic glycosaminoglycan, lipid and water contents in human coronary arterial branches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Acidic glycosaminoglycans in human atherosclerotic cerebral arterial tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Arterial wall proteoglycans--biological properties related to pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity--a role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900650-5

10.1016/S0021-9150(01)00650-5

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference